NEVRO CORP. Proceeds from Convertible Debt
NEVRO CORP. reported Proceeds from Convertible Debt of $189.75 million for the 12-month period ending 2020-12-31, per its 10-K filed 2023-02-21.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromConvertibleDebt · last filed 2023-02-21
- NEVRO CORP. proceeds from convertible debt for the quarter ending 2020-12-31 was $0.00.
- NEVRO CORP. proceeds from convertible debt for the quarter ending 2020-09-30 was $0.00.
- NEVRO CORP. proceeds from convertible debt for the quarter ending 2016-12-31 was $0.00.
- NEVRO CORP. proceeds from convertible debt for the quarter ending 2016-09-30 was $0.00.
- NEVRO CORP. proceeds from convertible debt for fiscal 2020 was $189.75M.
- NEVRO CORP. proceeds from convertible debt for fiscal 2016 was $172.50M.
| Period end | Proceeds from Convertible Debt 3 month | Proceeds from Convertible Debt 6 month | Proceeds from Convertible Debt 9 month | Proceeds from Convertible Debt 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $0.00 derived: sum of 2 quarters · filed 2023-02-21 | $189.75M 10-K · filed 2023-02-21 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $189.75M 10-Q · filed 2021-11-08 | ||
| 2020-06-30 | $189.75M 10-Q · filed 2021-08-04 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | $0.00 derived: sum of 2 quarters · filed 2019-02-21 | $172.50M 10-K · filed 2019-02-21 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | $172.50M 10-Q · filed 2017-11-06 | ||
| 2016-06-30 | $172.50M 10-Q · filed 2017-08-07 |